Sage Therapeutics Inc.’s stock fell 2.4% Wednesday, headed for a fresh all-time low after the company said it would cease developing a treatment for cognitive impairment associated with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback